Serotypes and antimicrobial resistance in Haemophilus influenzae in a hospital practice

Annals of the Academy of Medicine Singapore

Volumn 25, Issue 2, 1996, Pages 184-187

  Tee, N W S ^a   Lin, R V T P ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

children; elderly; invasive; type b

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; COTRIMOXAZOLE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CHILD; HAEMOPHILUS INFLUENZAE; HOSPITAL INFECTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; SEROTYPE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HOSPITALS; HUMANS; INCIDENCE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RISK FACTORS; SINGAPORE;

EID: 0029979157     PISSN: 03044602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Makela P H, Takala A K, Pettola H, Eskola J. Epidemiology of invasive Haemophilus influenzae type b disease. J Infect Dis 1992; 165:S2-6.
2. Musher E M, Kubitschek K R, Crennan J, Baughn R E. Pneumonia and acute febrile tracheobronchitis due to H. influenzae. Ann Intern Med 1983; 99:444-50.
3. Farley M M, Stephens D S, Brachman P S Jr, Harvey R C, Smith J D, Wenger J D, et al. Invasive H influenzae disease in adults: population-based surveillance Ann Intern Med 1992; 116.806-12
4. Centers for Disease Control. Haemophilus type b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children 2 months and older. Recommendations of the Immunization Practices Advisory Committee (ACIP). Morb Mortal Wkly Rep 1991; 40(RR-1):1-7.
5. Vadheim C M, Greenberg D P, Erikson E. Eradication of Haemophilus influenzae type b disease in Southern California. Arch Paediatr Adolesc Med 1994; 148.51-6
6. Campos J M. Haemophilus. In: Murray P R, Baron E J, Pfaller M A, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology,6thed. Washington, DC: ASM Press, 1995:556-65.
7. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Test, 5th ed. Approved standard M2-A5. Villanove, Pa: National Committee for Clinical Laboratory Standards, 1993.
8. Wenger J D, Pierce R, Dearer K, Franklin R, Bosley G, Pigott N Invasive Haemophilus influenzae disease: A population-based evaluation of the role of capsular polysaccharide serotype. J Infect Dis 1992; 165(Suppl 1):S34-35.
9. Falla T J, Dobson S R, Crook D W, Kraak W A, Nichols W W, Anderson E C, et al. Population-based study of non-typable Haemophilus influenzae invasive disease in children and neonates. Lancet 1993; 341:851-4.
10. Gilbert G L, Clements D A, Broughton S. Haemophilus influenzae type b infection in Victoria, Australia 1985-87: A population-based study to determine the need for immunization. Pediatr Infect Dis J 1990; 9:252-7.